The European Commission said on Thursday it had concluded exploratory talks with CureVac regarding the purchase of 225 million doses of the German biotech firm’s potential COVID-19 vaccine. “Today we…

Read more »

The post EU, CureVac in Talks on 225 Million Doses of Potential COVID-19 Vaccine appeared first on Hamodia.

In related news:

  1. U.S. Secures 300 Million Doses of Potential COVID-19 Vaccine
  2. U.K. Buys More Potential COVID-19 Vaccines From J&J and Novavax
  3. Britain Secures 90 Million Possible COVID-19 Vaccine Doses From Pfizer/BioNTech, Valneva
  4. Moderna to Provide 100 Million Doses of COVID-19 Vaccine to U.S.
  5. AstraZeneca Agrees to Supply Europe With 400 Million Doses of COVID-19 Vaccine